types of glp 1 drugs GLP-1 Drug Comparison in Diabetes and Obesity Treatment Indications for GLP-1/GIP RA Summary

Heterogeneity was assessed using the I 2 statistic and Cochrans Q test

Bydureon BCise (exenatide extended-release) injection, for subcutaneous use: prescribing information

Moderation is the minimum recommendation, and many users choose to reduce or eliminate alcohol during treatment

Particular attention is warranted for diverse populations, including older adults, individuals with advanced renal disease, pregnant patients, and those at risk of lean mass loss during rapid weight reduction

Use caution in a patient with a history of angioedema or anaphylaxis with another GLP-1 receptor agonist Acute Gallbladder Disease: Acute events of gallbladder disease such as cholelithiasis or cholecystitis have been reported in GLP-1 receptor agonist trials and postmarketing